Hantavirus vaccine in 2026?
6%chance of Yes
-1%in the last 24h
Odds over time
Yes probability, past weekWhy it's moving
Hantavirus vaccine in 2026? at 6%
On Polymarket, "Hantavirus vaccine in 2026? " is trading at 6% YES with $119,637 in volume.
💬 Ask this market
PRO+Key facts
- Total volume
- $120K
- traded all-time
- 24h volume
- $1.7K
- last 24 hours
- Resolves
- Dec 31, 2026
- settlement date
- Market
- Polymarket
- data source
🐋 Smart money on this market
recent notable tradesResolution details
This market will resolve to "Yes" if any vaccine intended for humans and inoculating against Hantavirus (including Hantavirus Pulmonary Syndrome (HPS) or Hemorrhagic Fever with Renal Syndrome (HFRS)) receives full approval from the U.S. Food and Drug Administration between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The primary resolution source for this market will be official information from the FDA, including its list of approved vaccines (https://www.fda.gov/vaccines-blood-biologics/vaccines/vaccines-licensed-use-united-states), however a consensus of credible reporting may also be used.
More in Markets
View all →
Odds and volume are sourced live from Polymarket and refresh continuously. WyldMarkets is a discovery and research tool — we don't accept bets or hold funds.
